当前位置: X-MOL 学术Acta Pharm. Sin. B › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Carbazole and tetrahydro-carboline derivatives as dopamine D3 receptor antagonists with the multiple antipsychotic-like properties
Acta Pharmaceutica Sinica B ( IF 14.7 ) Pub Date : 2023-07-27 , DOI: 10.1016/j.apsb.2023.07.024
Zhongtang Li 1 , Fan Fang 1 , Yiyan Li 1 , Xuehui Lv 1 , Ruqiu Zheng 1 , Peili Jiao 1 , Yuxi Wang 1 , Guiwang Zhu 1 , Zefang Jin 1 , Xiangqing Xu 2 , Yinli Qiu 2 , Guisen Zhang 3 , Zhongjun Li 1 , Zhenming Liu 1 , Liangren Zhang 1
Affiliation  

Dopamine D3 receptor (D3R) is implicated in multiple psychotic symptoms. Increasing the D3R selectivity over dopamine D2 receptor (D2R) would facilitate the antipsychotic treatments. Herein, novel carbazole and tetrahydro-carboline derivatives were reported as D3R selective ligands. Through a structure-based virtual screen, ZLG-25 (D3R Ki = 685 nmol/L; D2R Ki > 10,000 nmol/L) was identified as a novel D3R selective bitopic ligand with a carbazole scaffold. Scaffolds hopping led to the discovery of novel D3R-selective analogs with tetrahydro-β-carboline or tetrahydro-γ-carboline core. Further functional studies showed that most derivatives acted as hD3R-selective antagonists. Several lead compounds could dose-dependently inhibit the MK-801-induced hyperactivity. Additional investigation revealed that 23j and 36b could decrease the apomorphine-induced climbing without cataleptic reaction. Furthermore, 36b demonstrated unusual antidepressant-like activity in the forced swimming tests and the tail suspension tests, and alleviated the MK-801-induced disruption of novel object recognition in mice. Additionally, preliminary studies confirmed the favorable PK/PD profiles, no weight gain and limited serum prolactin levels in mice. These results revealed that 36b provided potential opportunities to new antipsychotic drugs with the multiple antipsychotic-like properties.



中文翻译:


咔唑和四氢咔啉衍生物作为多巴胺 D3 受体拮抗剂,具有多种抗精神病样特性



多巴胺 D 3受体 (D 3 R) 与多种精神病症状有关。增加D 3 R 相对于多巴胺D 2受体(D 2 R)的选择性将有利于抗精神病治疗。在此,新型咔唑和四氢咔啉衍生物被报道为D 3 R选择性配体。通过基于结构的虚拟筛选,ZLG-25(D 3 R K i = 685 nmol/L;D 2 R K i > 10,000 nmol/L)被鉴定为具有咔唑支架的新型D 3 R选择性双位配体。支架跳跃导致了具有四氢-β-咔啉或四氢-γ-咔啉核心的新型D 3 R-选择性类似物的发现。进一步的功能研究表明,大多数衍生物可作为 hD 3 R 选择性拮抗剂。几种先导化合物可以剂量依赖性地抑制 MK-801 诱导的多动症。进一步的研究表明, 23j36b可以减少阿扑吗啡引起的攀爬,而不会出现惊厥反应。此外, 36b在强迫游泳测试和悬尾测试中表现出不寻常的抗抑郁样活性,并减轻了 MK-801 引起的小鼠新物体识别的破坏。此外,初步研究证实了小鼠体内良好的 PK/PD 曲线、体重没有增加且血清催乳素水平有限。这些结果表明, 36b为具有多种抗精神病药样特性的新型抗精神病药物提供了潜在的机会。

更新日期:2023-07-27
down
wechat
bug